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Pharmacology and Therapeutics, McGill University, Montreal, CanadaABSTRACT Fibroblasts are activated in heart failure (HF) and produce fibrosis, which plays a role in maintaining atrial fibril-
lation (AF). The effect of HF on fibroblast ion currents and its potential role in AF are unknown. Here, we used a patch-clamp
technique to investigate the effects of HF on atrial fibroblast ion currents, and mathematical computation to assess the poten-
tial impact of this remodeling on atrial electrophysiology and arrhythmogenesis. Atrial fibroblasts were isolated from control
and tachypacing-induced HF dogs. Tetraethylammonium-sensitive voltage-gated fibroblast current (IKv,fb) was significantly
downregulated (by ~44%), whereas the Ba2þ-sensitive inward rectifier current (IKir,fb) was upregulated by 79%, in HF animals
versus controls. The fibroblast resting membrane potential was hyperpolarized (535 2 mV vs. 425 2 mV in controls) and
the capacitance was increased (29.7 5 2.2 pF vs. 17.8 5 1.4 pF in controls) in HF. These experimental findings were
implemented in a mathematical model that included cardiomyocyte-fibroblast electrical coupling. IKir,fb upregulation had a
profibrillatory effect through shortening of the action potential duration and hyperpolarization of the cardiomyocyte resting
membrane potential. IKv,fb downregulation had the opposite electrophysiological effects and was antifibrillatory. Simulated
pharmacological blockade of IKv,fb successfully terminated reentry under otherwise profibrillatory conditions. We conclude
that HF induces fibroblast ion-current remodeling with IKv,fb downregulation and IKir,fb upregulation, and that, assuming cardi-
omyocyte-fibroblast electrical coupling, this remodeling has a potentially important effect on atrial electrophysiology and
arrhythmogenesis, with the overall response depending on the balance of pro- and antifibrillatory contributions. These findings
suggest that fibroblast Kþ-current remodeling is a novel component of AF-related remodeling that might contribute to
arrhythmia dynamics.INTRODUCTIONAtrial fibrillation (AF) is the most common sustained
arrhythmia in the general population and is associated
with significant cardiovascular morbidity and mortality
(1,2). The failure of randomized clinical trials to demon-
strate a benefit from sinus-rhythm-maintaining antiar-
rhythmic therapy, which has often been attributed to the
suboptimal efficacy and significant proarrhythmic potential
of antiarrhythmic drugs (3), highlights our incomplete un-
derstanding of the basic pathophysiology of AF.
At the cellular level, it is well known that AF induces
cardiomyocyte electrical remodeling and atrial fibrosis,
forming the basis for longer-lasting forms of AF (4–7).
Traditionally, fibroblasts were thought to be relevant to
arrhythmogenesis primarily because they produce extra-
cellular matrix, which serves as a structural barrier that af-
fects anisotropic conduction and creates conduction block
(8–11). However, recent work has modified this paradigm
by suggesting that cardiac fibroblasts may couple electri-
cally to atrial cardiomyocytes and modulate their electro-Submitted June 16, 2014, and accepted for publication October 8, 2014.
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arrhythmogenesis (12). Cardiomyocyte-fibroblast electri-
cal interactions have been studied in cocultured cell
systems (13–18) and mathematical models (19,20), and
postulated to contribute to the pathogenesis of AF
(12,19), although in vivo evidence of such interactions is
lacking. Cardiomyocyte ion-channel remodeling is known
to play an important role in AF pathophysiology (21).
Fibroblasts also possess ion channels, but their function
is much less well understood than those of cardiomyocytes
(12). The nature and potential significance of fibroblast
ion-channel remodeling associated with AF remain to be
evaluated. Here, we examined the remodeling of Kþ cur-
rents in fibroblasts freshly isolated from dogs with an
AF substrate associated with heart failure (HF). Freshly
isolated fibroblasts were used to preclude the effects of
cell culture, which can obscure the fibroblast remodeling
phenotype caused by HF (22). We then implemented
these experimental findings in a mathematical model
based on previous work (23) to investigate the potential
effects of fibroblast electrical remodeling on atrial car-
diomyocyte electrophysiological properties and arrhyth-
mogenesis, assuming cardiomyocyte-fibroblast electrical
coupling.http://dx.doi.org/10.1016/j.bpj.2014.10.014
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Animal model
Animal care procedures were approved by the Animal Research Ethics
Committee of the Montreal Heart Institute and followed National Institutes
of Health guidelines. We studied a total of 20 adult mongrel dogs (20–
30 kg), divided into control (CTL; n ¼ 10) and 2-week ventricular tachy-
pacing-induced HF (n ¼ 10) groups. HF dogs were anesthetized under
diazepam (0.25 mg/kg IV)/ketamine (5.0 mg/kg IV)/halothane (1–2%
PI) anesthesia so that two leads could be inserted under fluoroscopy into
the right ventricular apex (via the left jugular vein) and connected to a
pacemaker (St. Jude Medical, St. Paul, MN) implanted subcutaneously
in the neck. After 24 h of postoperative recovery, ventricular pacing was
initiated at 240 bpm for 2 weeks. On study days, the dogs were anesthe-
tized with morphine (2 mg/kg SC) and a-chloralose (120 mg/kg IV,
followed by 29.25 mg/kg/h) and ventilated mechanically. The atrial effec-
tive refractory period (aERP) and mean AF duration were measured at
basic cycle lengths (BCLs) of 150, 200 ms, 250 ms, 300 ms, and
350 ms in the right atrium. aERP was determined with 10 basic stimuli
(S1) followed by a premature extrastimulus (S2) in 5 ms decrements
(the longest S1-S2 interval that failed to capture defined the aERP). The
mean of three aERP values at each BCL was used for analysis. AF was
induced with atrial burst pacing at 10 Hz and 10 V. The mean AF duration
was based on 10 AF inductions in each dog. If the mean duration of the
first five episodes of AF was longer than 2 min, AF was only induced
five times. After in vivo study, the hearts were removed and immediately
immersed in oxygenated Tyrode solution containing (mmol/L) NaCl 136,
KCl 5.4, MgCl2 1, CaCl2 2, NaH2PO4 0.33, HEPES 5, and dextrose 10,
pH 7.35 (NaOH). Atrial tissue was subjected to enzymatic digestion as
described below for cell isolation.Fibroblast isolation
Atrial fibroblasts were obtained from the left atria of adult mongrel dogs
as described previously (24). The heart was removed after intra-atrial in-
jection of heparin (10,000 U) and immersed in Tyrode solution contain-
ing 2 mmol/L Ca2þ, and the left coronary artery was cannulated. The left
atrial (LA) tissue was then perfused with 2 mmol/L Tyrode solution
(37C, 100% O2), then with Ca
2þ-free Tyrode solution (~10 min), and
finally by ~60 min perfusion with the same solution containing collage-
nase II (~0.48 mg/mL; Worthington, Lakewood, NJ) and 0.1% bovine
serum albumin (BSA; Sigma, Sigma-Aldrich Canada Co., Oakville, On-
tario, Canada). Cells were dispersed by trituration in Kraftbru¨he (KB)
solution (for contents, see below). Filtration (500 mm micromesh) was
used to remove debris and cells were centrifuged at 800 rpm for
5 min to pellet cardiomyocytes. The supernatant was collected and
filtered through 30 mm nanomesh and centrifuged at 1500 rpm for
10 min to pellet fibroblasts. Pelleted, freshly isolated fibroblasts were
then separated.Ion current and membrane potential recording
All in vitro recordings were obtained at 37C. The whole-cell perforated-
patch technique was used to record resting membrane potentials (RMPs)
in current-clamp mode and the tight-seal patch clamp was used to record
Kþ current in voltage-clamp mode. Borosilicate glass electrodes (Sutter In-
strument) filled with pipette solution were connected to a patch-clamp
amplifier (Axopatch 200A; Axon). Electrodes had tip resistances of 6–8
MU. For perforated-patch formation, a nystatin-free intracellular solution
was in the tip of the pipette by capillary action (~30 s). The pipettes
were then back-filled with a nystatin-containing (600 mg/mL) pipette
solution. Currents are expressed as densities (pA/pF). Junction potentials
between bath and pipette solutions averaged 10.5 mV and were corrected
for RMP measurements only. IKir,fb was quantified as 300 mmol/LBa2þ-sensitive current. IKv,fb was quantified as current sensitive to
10 mmol/L tetraethylammonium (TEA) (24). The bath solution contained
(mmol/L) NaCl 136, CaCl2 1.8, KCl 5.4, MgCl2 1, NaH2PO4 0.33, dextrose
10, and HEPES 5, titrated to pH 7.3 with NaOH. The pipette solution con-
tained (mmol/L) GTP 0.1, potassium-aspartate 110, KCl 20, MgCl2 1,
MgATP 5, HEPES 10, sodium-phosphocreatine 5, and EGTA 0.005 (pH
7.4, KOH). The KB solution contained (mmol/L) KCl 20, KH2PO4 10,
dextrose 10, mannitol 40, L-glutamic acid 70, b-OH-butyric acid 10, taurine
20, EGTA 10, and 0.1% BSA (pH 7.3, KOH).Atrial cardiomyocyte and fibroblast mathematical
models
The Ramirez-Nattel-Courtemanche (RNC) ionic model of canine atrial car-
diomyocyte action potentials (APs) (25) was implemented and electrically
connected to a variable number (n) of MacCannell model fibroblasts (20)
via gap junctions of conductance Ggap. The total ionic current for the
RNC model (Iion,RNC) is
Iion;RNC ¼ INa þ IKir þ Ito þ IKur;d þ IKr þ IKs þ ICaL þ IClCa
þ IKACh þ IpCa þ INaCa þ INaK þ Ib;Na þ Ib;Ca
þ Ib;Cl þ nIgap
where IKir, Ito, IKur,d, IKr, IKs, and IKACh are the inward-rectifier-, transient-
outward-, ultrarapid delayed-rectifier-, rapid and slow delayed rectifier-,
and acetycholine (ACh)-activated Kþ currents respectively; ICaL is the
L-type Ca2þ current; IClCa is the Ca
2þ-activated Cl current; IpCa is
the Ca2þ pump current; INaCa is the Na
þ/Ca2þ exchange current; INaK is
the Naþ/Kþ pump current; and Ib,Na, Ib,Ca, and Ib,Cl are the background
Naþ, Ca2þ, and Cl currents, respectively (26). Igap is the gap-junction
current and n is the number of fibroblasts coupled to each cardiomyocyte.
The total ionic current for the MacCannell fibroblast model (Iion,fb) is
calculated as
Iion;fb ¼ IKv;fb þ IKir;fb þ INaK;fb þ Ib;Na;fb  Igap
where IKv,fb and IKir,fb are the fibroblast-delayed-rectifier and inward-recti-
fier Kþ currents, respectively, INaK,fb is the Na
þ/Kþ exchange pump current,
Ib,Na,fb is the background Na
þ current, and Igap is the gap junction current
(20).
Fibroblast electrical remodeling was simulated by scaling the fibroblast
IKv,fb and IKir,fb maximal conductance as follows: GKir,fb
0 ¼ fKir,fb  GKir,fb
and GKv,fb
0 ¼ fKv,fb GKv,fb, where Gx is the baseline conductance, fx is the
remodeling factor, and Gx
0 is the remodeled conductance. GKir,fb and GKv,fb
were set at 0.4822 nS/pF and 0.14 nS/pF, respectively, as described by Ashi-
hara et al. (23). We varied fKir,fb and fKv,fb independently with fKir,fb ¼
{1, 2.5, 5, 10} and fKv,fb ¼ {0.1, 0.25, 0.5, 0.75, 1}.Single-cell and cable simulations
A single cardiomyocyte with capacitance 100 pF (25) was connected to a
fibroblast through a gap junction with a gap-junction conductivity (Ggap)
of 3 nS. The cardiomyocyte was paced at a BCL of 250 ms and the cardi-
omyocyte transmembrane potential, fibroblast transmembrane potential,
gap-junction current (Igap), and total fibroblast potassium current (IK,fb)
were monitored under CTL and remodeled conditions. We then constructed
a 1D monodomain cable of atrial cardiomyocytes connected to fibroblasts
and simulated cardiomyocyte and fibroblast transmembrane potential,
Igap, IK,fb, and relevant electrophysiological parameters under CTL and re-
modeled conditions. Numerical integration of the single-cell model was
performed using the MATLAB ODE23s ordinary differential equation
solver (The MathWorks, Natick, MA).Biophysical Journal 107(10) 2444–2455
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We performed 2D simulations on a 5  10 cm sheet of RNC atrial
cells. The tissue contained cardiomyocyte cables (radius 5 mm, resistivity
75 U-cm, coupled by resistors of 300 kU (length 100 mm) inserted in a
brick-wall manner). Fiber resistivity and interfiber resistance values were
chosen to match experimental results (26,27). Fig. S1 in the Supporting
Material shows the fibroblast distribution used (the results presented
here were obtained at intermediate density (0.250), but analyses were
conducted with all three fibroblast distribution maps and produced
qualitatively similar results). Fibroblast proliferation was generated
through a recursive algorithm as described by Ashihara et al. (23). Reen-
trant spiral waves were initiated using an S1-S2 cross-shock protocol. We
investigated the initiation, maintenance, and termination dynamics, and
performed a dominant-frequency analysis by computing the frequency
domain amplitude of the fast Fourier transform of the pseudo-ECG, as
in previous work (28). Both the cable and 2D models were coded in C
and calculations were performed with a time step of 25 ms using up to
eight processors with an SGI Altix XE high-performance parallel proces-
sor (Westgrid).RESULTS
In vivo measurements
In vivo electrophysiological data and hemodynamic indices
are shown in Fig. 1. HF significantly increased aERP at all
BCLs (Fig. 1 A). Mean AF duration increased in HF dogs
(745 5 287 vs. 22 5 10 s in CTL; Fig. 1 B). Systolic
and diastolic pressures were reduced in HF dogs, whereas
left ventricular (LV) end-diastolic, LA, and right atrialFIGURE 1 In vivo electrophysiological data and hemodynamic indices. (A) A
(BCL). (B) AF duration. (C) Arterial blood pressure. (D) Left ventricular systoli
sure (LAP) and right atrial pressure (RAP). *p < 0.05, **p < 0.01, ***p < 0.0
Biophysical Journal 107(10) 2444–2455(RA) pressures were increased (Fig. 1, C–E), consistent
with the HF phenotype.Fibroblast Kv and Kir current remodeling in AF
Time- and voltage-dependent Kþ current (IKv,fb) was elicited
by 500 ms voltage-clamp steps to voltages ranging from
110 to þ70 mV. IKv,fb activated rapidly and showed little
inactivation, and was reversibly suppressed by 30 mmol/L
TEA (Fig. 2, A and B). HF strongly downregulated the
TEA-sensitive Kþ current (Fig. 2 B). Mean current density-
voltage relations (Fig. 2 C) showed statistically significant
decreases in IKv,fb (by ~70%) in HF fibroblasts over a wide
range of voltages. LA fibroblasts had membrane capaci-
tances of 17.85 1.4 (n ¼ 33) and 29.75 2.2 (n ¼ 33, p <
0.001 versus CTL) pF inCTL andHF, respectively (Fig. 2D).
Kir currents (IKir,fb) recorded from CTL and HF atrial fi-
broblasts are shown in Fig. 3 A. Current induced with a ramp
depolarization at baseline before Ba2þ and current in the
presence of 300 mmol/L Ba2þ are shown for individual cells
obtained for each condition. Fig. 3 B shows the mean den-
sity of IKir,fb as a function of test voltage. At120 mV, IKir,fb
averaged1.45 0.6 in CTL (n¼ 15) and2.65 0.3 (n¼
10) pA/pF in HF fibroblasts, an 86% increase (p < 0.001).
Consistent with inward-rectifier current upregulation in
HF, RMP averaged 42 5 2 mV in CTL (n ¼ 16) and
53 5 2 mV in HF (n ¼ 19, p < 0.01 versus CTL) fibro-
blasts (Fig. 3 C).trial effective refractory period (aERP) as a function of basic cycle length
c pressure (LVSP) and end-diastolic pressure (LVEDP). (E) Left atrial pres-
01 versus CTL.
FIGURE 2 Experimental recordings of the
TEA-sensitive current (IKv,fb). (A) Current den-
sities at baseline (BL), after 30 mM TEA, and
upon washout (WO) in a CTL atrial fibroblast
(voltage protocol in inset). (B) Same as A, but for
HF cells. (C) TEA-sensitive current density as a
function of test potential (TP). (D) Fibroblast
membrane capacitance (Cm,fb). Results are mean
5 SEM. ***p < 0.001 versus CTL.
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atrial cardiomyocyte AP
Fig. 4 shows the model-simulated cardiomyocyte trans-
membrane potential (Vm; Fig. 4 A), fibroblast transmem-
brane potential (Vm,fb; Fig. 4 B), gap-junction current(Igap; Fig. 4 C) and total fibroblast K
þ current (IK,fb; Fig. 4
D), with progressive IKv,fb downregulation for a cardiomyo-
cyte paced at 4 Hz coupled to two fibroblasts by a gap-junc-
tion conductivity of 3 nS. Downregulation of fibroblast IKv,fb
decreased the total fibroblast Kþ current (Fig. 4D), reducingFIGURE 3 Experimental recordings for Kir cur-
rent (IKir,fb). (A) Current densities for CTL (left)
and HF (right) obtained with a ramp protocol
before and after addition of 300 mM Ba2þ. (B)
Current densities as a function of TP. (C)
Resting membrane potential (RMP). Results are
mean 5 SEM. **p < 0.01, ***p < 0.001 versus
CTL.
Biophysical Journal 107(10) 2444–2455
FIGURE 4 (A–D) Effect of fibroblast IKv,fb
downregulation on (A) cardiomyocyte transmem-
brane potential (Vm), (B) fibroblast transmembrane
potential (Vm,fb), (C) gap-junction current (Igap),
and (D) total fibroblast Kþ current (IK,fb). Progres-
sive IKv,fb downregulation decreased the fibroblast
repolarizing Kþ current density, making the fibro-
blast behave as a current source during phases 2
and 3 of the cardiomyocyte AP, leading to APD
prolongation. The cardiomyocyte RMP was depo-
larized by IKv,fb downregulation, leading to partial
INa inactivation. Results were obtained with two
fibroblasts connected to a cardiomyocyte paced at
4 Hz with a Ggap of 3 nS. CTL ¼ single-cardio-
myocyte action potential in the absence of fibro-
blast coupling. To see this figure in color, go
online.
2448 Aguilar et al.the fibroblast repolarizing current. This had the effect of
increasing the gap-junction current flow from the fibroblast
to the cardiomyocyte during phases 2 and 3 of the cardio-
myocyte AP (Fig. 4 C), thereby making the fibroblast a
source of depolarizing current. This depolarizing current
led to progressive cardiomyocyte APD prolongation
(Fig. 4 A). IKv,fb downregulation also had a depolarizing ef-
fect on the cardiomyocyte RMP.
Fig. 5, A–D, show the same variables as in Fig. 4, but
for graded IKir,fb upregulation. Upregulation of IKir,fb pro-
gressively increased the total fibroblast Kþ current (Fig. 5
D), thus increasing the fibroblast repolarizing current.
This effect increased the gap-junction current from the
cardiomyocyte to the fibroblast, thereby making the fibro-
blast a current sink for the cardiomyocyte and shortening
the cardiomyocyte APD (Fig. 5 A). IKir,fb upregulation
also had a hyperpolarizing effect on the RMP, helping
to maintain Naþ current availability during phase 0 of
the AP.Graded effects of fibroblast electrical remodeling
on atrial tissue RMP, APD90, and conduction
velocity
We determined the effects of fibroblast ion-current re-
modeling on cardiomyocyte cellular electrical properties
by simulating activation of a cable over a wide range of
pacing frequencies to vary the diastolic interval (DI).
Fig. S2 shows the RMP (Fig. S2 A), AP duration (APD)Biophysical Journal 107(10) 2444–2455at 90% repolarization (APD90; Fig. S2 B), and conduction
velocity (CV; Fig. S2 C) as a function of DI for IKv,fb
downregulation (red) and IKir,fb upregulation (green)
over a 10 cm cable with two fibroblasts per cardiomyo-
cyte and a Ggap of 3 nS. IKv,fb downregulation had a small
depolarizing effect on the cardiomyocyte RMP but sub-
stantially prolonged APD compared with CTL (e.g.,
APD90 values at BCL ¼ 500 ms for fKv,fb ¼ 1.0, 0.75,
0.5, and 0.25 were 162 ms, 175 ms, 194 ms, and
225 ms, respectively; RMP values were 76.9 mV,
76.8 mV, 76.6 mV, and 76.4 mV, respectively). Con-
duction velocities paralleled the conduction velocities for
the CTL condition over the spectrum of fKv,fb under
investigation.
IKir,fb upregulation had the opposite effect on repolariza-
tion and resting potentials, i.e., it significantly hyperpolar-
ized the cardiomyocyte RMP and shortened the APD90
versus CTL (APD90 values at BCL ¼ 500 ms for fKir,fb ¼
1.0, 2.5, 5.0, and 10 were 162 ms, 152 ms, 137 ms, and
115 ms, respectively, with corresponding RMP values of
76.9 mV, 78.22 mv, 79.7 mV, and 81.2 mV, respec-
tively). IKir,fb upregulation reduced CVs at long DIs
compared with CTL, but CVs were increased compared
with CTL at DIs of <150 ms, highlighting the biphasic
effect of RMPs on the CV and the prolongation of
the Naþ channel recovery time constant at more positive
RMPs (27) (e.g., at DI z 62 ms, CVs for fKir,fb ¼
1.0, 2.5, 5.0, and 10 were 72.2 cm/s, 78.4 cm/s,
85.4 cm/s, and 89.5 cm/s, respectively). A 1:1 conduction
FIGURE 5 (A–D) Effect of fibroblast IKir,fb
upregulation on the (A) cardiomyocyte transmem-
brane potential (Vm), (B) fibroblast transmembrane
potential (Vm,fb), (C) gap-junction current (Igap),
and (D) total fibroblast Kþ current (IK,fb). IKir,fb up-
regulation increases fibroblast repolarizing Kþ cur-
rent density, making the fibroblast behave as a
current sink during phases 2 and 3 of the myocyte
AP, leading to APD shortening. The cardiomyo-
cyte was hyperpolarized by IKir,fb upregulation,
preserving Naþ channel availability. Results were
obtained with two fibroblasts connected to a cardi-
omyocyte paced at 4 Hz with a Ggap of 3 nS.
CTL ¼ single-cardiomyocyte action potential in
the absence of fibroblast coupling. To see this
figure in color, go online.
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fKir,fb (Fig. S2 B).Effect of fibroblast electrical remodeling on 2D
spiral-wave dynamics
Fig. 6 shows the APD90 distribution over a 2D sheet of atrial
cardiomyocytes with moderate fibrosis density and two fibro-
blasts per cardiomyocyte, with a Ggap of 3 nS, for progressive
IKir,fb upregulation (Fig. 6, top row) and IKv,fb downregulation
(Fig. 6, bottom row). In accordancewith the single-cell and ca-
ble analyses, mean APD90 was progressively shortened by
IKir,fb upregulation (mean APD90 values for fKir,fb ¼ 1.0, 2.5,
5.0, and 10 were 121 ms, 116 ms, 107 ms, and 81 ms, respec-
tively; Fig. 6, A–D). The APD90 dispersion, as quantified by
the APD90 coefficient of variation, increased with IKir,fb upre-
gulation (e.g., the coefficients ofvariation forCTLand fKir,fb¼
10 were 0.8% and 6.2%, respectively). IKv,fb downregulation
(Fig. 6,E–H) prolonged themeanAPD90 (meanAPD90 values
for fKv,fb ¼ 1.0, 0.75, 0.5, and 0.25 were 121 ms, 134 ms,
154 ms, and 159 ms, respectively) and increased the coeffi-
cient of variation to an extent similar to that observed for IKir,fb
upregulation (coefficients of variation for CTL and fKv,fb ¼
0.25 were 0.8% and 6.2%, respectively). Fig. S3 illustrates
the increasing spatial variability ofAPDdue to heterogeneous
distribution of fibroblasts as a function of ion-current remod-
eling, by showing results as a heatmap of APD deviations
around the mean under each condition.
Fig. 7 A shows snapshots of the cardiomyocyte trans-
membrane potential as a function of time over a 2D sheetof cardiomyocytes for progressive IKir,fb upregulation with
IKv,fb at its CTL value. For the nonremodeled condition
(fKir,fb ¼ 1, fKv,fb ¼ 1, first column), the wavefront quickly
drifted out of the substrate and became extinguished on
the right boundary after completing a single revolution.
For intermediate IKir,fb upregulation (fKir,fb ¼ 2.5, second
column), the wavefront completed about three revolutions
before terminating. At higher levels of IKir,fb upregulation
(fKir,fb ¼ 5 and 10), the wavefront was successfully con-
tained within the substrate boundaries, leading to sustained
reentry. Fig. 7 B shows the rotor trajectories of the 2D
substrate for the corresponding simulations: as fKir,fb was
increased, the rotor stabilized into a more compact, quasi-
periodic, rosette-like meandering pattern. Fig. S4 shows
the power spectra analysis for IKir,fb upregulation: the domi-
nant frequencies of rotors progressively increased with
increasing fKir,fb, passing from 5.7 to 6.1 and then 6.7 Hz.
The nonremodeled condition (fKir,fb ¼ 1, fKv,fb ¼ 1) termi-
nated after completing a single revolution, precluding a
formal calculation of the spiral wave’s dominant frequency
(it was estimated to be 4.6 Hz).
Fig. S5 A follows the same format as Fig. 7, but for IKv,fb
downregulation while keeping IKir,fb at the CTL value. As
described above, for the CTL condition (fKir,fb ¼ 1, fKv,fb ¼
1, leftmost column), the wavefront rapidly became extin-
guished on a substrate boundary. Similar dynamics are
observed with fKv,fb¼ 0.75 (fKir,fb¼ 1, fKv,fb¼ 0.75, second
column). With 2- and 4-fold IKv,fb downregulation, the
wavefront failed to depolarize neighboring cardiomyocytes,
also leading to propagation failure and reentry terminationBiophysical Journal 107(10) 2444–2455
FIGURE 6 (A–H) APD90 distribution over a 2D sheet of cardiomyocytes with patchy fibrosis (two fibroblasts with a Ggap of 3 nS per cardiomyocyte) in the
2D model for IKir,fb upregulation (top row, A–D) and IKv,fb downregulation (bottom row, E–H). APD90 was reduced by IKir,fb upregulation and increased by
IKv,fb downregulation. Values above each panel are mean5 SD APD90 across the substrate. To see this figure in color, go online.
2450 Aguilar et al.with qualitatively similar dynamics (fKir,fb ¼ 1, fKv,fb ¼ 0.5
and 0.25, third and fourth columns). Fig. S5B shows the
rotor trajectories for the corresponding simulations; all three
trajectories had the same morphology. Hence, IKv,fb downre-
gulation did not facilitate reentry, and reentry was not sus-
tained long enough to allow for determination of the
dominant frequency.
We then investigated the effect of combined IKir,fb upre-
gulation and IKv,fb downregulation on reentry dynamics.
Fig. 8, A and B, show representative examples of the dy-
namics observed under CTL conditions (fKir,fb ¼ 1, fKv,fb ¼
1), with IKv,fb downregulation (fKir,fb ¼ 1, fKv,fb ¼ 0.25),
IKir,fb upregulation (fKir,fb¼ 5, fKv,fb¼ 1), and IKir,fb upregu-
lation with the addition of IKv,fb suppression (fKir,fb ¼ 5,
fKv,fb ¼ 0), along with corresponding rotor trajectories.
IKir,fb upregulation stabilized the primary rotor, leading
to sustained reentry (Fig. 8 A, third column versus first
column). Keeping IKir,fb at proarrhythmic conditions but
simulating the addition of an IKv,fb blocker by IKv,fb downre-
gulation (Fig. 8 A, fourth column) successfully terminated
reentry, and the rotor dynamics (Fig. 8 B) became qualita-
tively similar to the CTL condition. In summary, the ar-
rhythmogenic effect of fibroblast remodeling is strongly
dependent on the relative degree of IKv,fb downregulationBiophysical Journal 107(10) 2444–2455and IKir,fb upregulation, and IKv,fb suppression is able to
terminate AF under proarrhythmic conditions.
Fig. S6 shows the model-predicted effects of the average
experimentally observed change in IKir,fb and IKv,fb remod-
eling on AF vulnerability. With two fibroblasts per cardio-
myocyte, the spiral-wave dynamics were similar to those in
the nonremodeled condition, with reentry terminating
shortly after initiation. However, with four fibroblasts
per cardiomyocyte, the HF-induced fibroblast ionic remod-
eling effect was greater, leading to more complex reentry
dynamics and greater spiral-wave persistence compared
with CTL. HF also increased fibroblast capacitance
(Cm,fb), at least in part by increasing fibroblast size
(Fig. S7). This increase would be expected to enhance
the electrotonic influence of fibroblasts on coupled cardio-
myocytes. The result of reproducing experimental HF-in-
duced Cm,fb increases is also shown in Fig. S6. The
HF-induced Cm,fb remodeling prolonged the time to termi-
nation and qualitatively increased the rotor trajectory
complexity for two fibroblasts per cardiomyocyte, whereas
it had the opposite effect with four fibroblasts per cardio-
myocyte. These discrepant changes result from the fact
that Cm,fb increases enhance the effects of both profibrilla-
tory IKir,fb increases and antifibrillatory IKv,fb decreases,
FIGURE 7 (A) Spiral-wave dynamics over time for progressive IKir,fb upregulation and fixed IKv,fb. White dots identify the rotor-tip phase singularities. In
the CTL condition (fKir,fb¼ fKv,fb¼ 1), the phase singularity drifts rapidly and is extinguished on a boundary. With fKir,fb¼ 2.5, the spiral wave completes one
complete revolution before it is extinguished. With fKir,fb ¼ 5 and 10, reentry is sustained. (B) Rotor trajectory for the corresponding simulations in A. To see
this figure in color, go online.
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two.DISCUSSION
The main findings from this study are that 1), HF induces
fibroblast ion-current remodeling by downregulating IKv,fb
and upregulating IKir,fb; 2), in the presence of appreciable
cardiomyocyte-fibroblast electrical coupling, fibroblast
ionic remodeling affects the electrophysiology of coupled
cardiomyocytes; and 3), atrial arrhythmogenesis is altered
by fibroblast ion-current remodeling, with IKv,fb downregu-
lation having an antifibrillatory effect and IKir,fb upregula-
tion having a profibrillatory effect. To our knowledge, this
is the first report to describe fibroblast ionic current remod-
eling in the setting of HF and investigate the potential ef-
fects of this remodeling on atrial arrhythmogenesis.Relation to previous studies of fibroblast ion
currents
The properties of IKir,fb and IKv,fb described in this work are
grossly similar to those reported in prior studies of rat (29),
canine (22,24), and human (30) fibroblasts. The downregu-
lation of IKv,fb reported here is similar to our observations in
previous work, both in fibroblasts from HF animals andoccurring spontaneously under cell-culture conditions
(22,24). We are not aware of any previous reports of IKir,fb
remodeling in HF. The fibroblast RMP was hyperpolarized
in HF compared with CTL (53 5 2.1 vs. 42 5
1.9 mV) because of upregulation of IKir,fb, as the inward-
rectifier current is the primary determinant of the fibroblast
RMP (31). Our simulated nonremodeled fibroblast RMP
closely matched the experimental measurements (experi-
mental and simulated RMPs were 42 5 1.9 vs.
43.2 mV, respectively). In our experiments, the baseline
Cm,fb was somewhat larger than that previously reported
for rat ventricular fibroblasts (17.8 5 1.4 vs. 6.3 pF) (29)
and greatly increased in HF animals (29.75 2.2 pF), closer
to the value of 53 pF reported for rat ventricular myofibro-
blasts (29) and passages 2–6 human fibroblasts (30). The
differences among these studies may be due to the species,
tissues, and study conditions used.Potential role of fibroblast electrical remodeling
in atrial arrhythmogenesis
There is extensive evidence from in vitro and simulation
models that fibroblast coupling to cardiomyocytes can alter
cardiac electrical activity and promote arrhythmogenesis
(12), although clear in vivo evidence is lacking. Fibroblasts
can couple cardiomyocytes over extended distances,Biophysical Journal 107(10) 2444–2455
FIGURE 8 (A) Spiral-wave dynamics for representative cases of mixed IKir,fb upregulation and IKv,fb downregulation. Downregulation of IKv,fb terminates
reentry after fewer revolutions under CTL conditions. Conversely, IKir,fb upregulation leads to sustained reentry. Simulating the addition of an IKv,fb blocker
under proarrhythmic conditions (last column) demonstrates the potential antiarrhythmic effect of IKv,fb blockade, with reentry termination occurring promptly
where reentry had previously been sustained. (B) Trajectories of spiral-wave rotor-core tip corresponding to cases in A. To see this figure in color, go online.
2452 Aguilar et al.producing arrhythmogenic coupling delays (15). Cardiac
injury promotes fibroblast-cardiomyocyte interactions,
enhancing their ability to contribute to arrhythmia formation
(32). Coculture of myofibroblasts with cardiomyocytes is
associated with electrotonic coupling that is highly arrhyth-
mogenic (18). Mathematical modeling work suggests that
cardiomyocyte-fibroblast interactions contribute to conduc-
tion abnormalities in arrhythmogenic LA posterior walls
from HF animals (11) and to complex fractionated electro-
gram patterns in patients (23).
Mathematical modeling has been applied extensively
to assess the potential electrophysiological consequences
of fibroblast-cardiomyocyte coupling. Key determinants
include the size of individual fibroblasts relative to cardi-
omyocytes, the number of fibroblasts coupled to cardio-
myocytes, and fibroblast density (18–20,34–36). Here,
we introduced a determinant that to our knowledge has
not been examined before: changes in fibroblast Kþ-chan-
nel properties resulting from phenotypic alterations
induced by cardiac pathology. We investigated the func-
tional effect of fibroblast electrical remodeling on atrial ar-
rhythmogenesis by independently upregulating IKir,fb and
downregulating IKv,fb. IKir,fb upregulation proved to be pro-
fibrillatory, whereas IKv,fb downregulation was antifibrilla-
tory. As summarized in Fig. S8, the profibrillatory effect of
fibroblast IKir,fb upregulation was mediated through anBiophysical Journal 107(10) 2444–2455increased fibroblast repolarizing current. This made the
fibroblast act as a current sink for the cardiomyocyte, lead-
ing to 1), hyperpolarization of the atrial cardiomyocyte
RMP and increased cardiomyocyte INa availability; and
2), shortening of the atrial cardiomyocyte APD, thereby
preserving cardiomyocyte excitability and facilitating con-
duction and reentry at higher frequencies (such as those of
AF). In contrast, the antifibrillatory effect of IKv,fb downre-
gulation was mediated through a decrease in fibroblast
repolarizing current. This made the fibroblast act as a
current source for the cardiomyocyte, leading to 1),
depolarization of the atrial cardiomyocyte RMP and
decreased INa availability; and 2), prolongation of the
APD, thereby decreasing cardiomyocyte excitability and
impeding reentry.
Our findings are conceptually consistent with previous
work on AF-induced cardiomyocyte remodeling by Pandit
et al. (37), in which they described the rotor-stabilizing ef-
fects of atrial cardiomyocyte IKir,fb-equivalent (IK1) upregu-
lation. They found that cardiomyocyte IK1 upregulation
hyperpolarized the RMP, thereby increasing INa availability
and shortening the APD. This is similar to what we observed
with IKir,fb upregulation facilitating reentry and maintenance
of the rotor underlying AF. In our study, the cardiomyocyte
was hyperpolarized through a novel (to our knowledge) in-
direct mechanism (i.e., fibroblast electrical remodeling and
Fibroblast Ionic Remodeling and AF 2453cardiomyocyte-fibroblast electrical interaction) in the
absence of intrinsic cardiomyocyte IK1 upregulation.
To clarify their individual effects, we performed most of
our analyses of IKir,fb and IKv,fb remodeling by indepen-
dently up- or downscaling individual current conductances.
However, the experimental data show that IKv,fb and IKir,fb
remodeling occurred simultaneously. Therefore, we inves-
tigated the effect of simultaneous IKv,fb downregulation and
IKir,fb upregulation (Fig. S6), and found that the balance be-
tween these opposing effects determines the consequences
of fibroblast ion-current remodeling on AF properties. Us-
ing experimentally obtained values for IKir,fb upregulation
and IKv,fb downregulation, we found that HF-induced fibro-
blast ionic remodeling has the capacity to promote AF
(Fig. S6) while prolonging the effective refractory period,
as observed experimentally (Tables S1 and S2). However,
for a given upregulated fKir,fb, one could observe sustained
reentry, nonsustained reentry, or no reentry at all depend-
ing on the degree of IKv,fb downregulation. With our
first-order model, it is difficult to directly correlate the
magnitude of the experimentally observed remodeling
with mathematical-model predictions regarding atrial ar-
rhythmogenesis. Nevertheless, IKv,fb had to be downregu-
lated to extreme values before it could counterbalance
modest IKir,fb upregulation. Atrial cardiomyocyte ionic-cur-
rent remodeling also occurs in HF (38). Implementing both
cardiomyocyte and fibroblast ionic modeling (Tables S1
and S2), we found that the cardiomyocyte ionic remodel-
ing previously reported to prolong the APD and ERP
(38) makes reentry maintenance more difficult, but does
not otherwise alter the qualitative properties of AF associ-
ated with fibroblast ionic remodeling as described here
(Fig. S9).Novelty and potential importance
The notion that atrial ion-current remodeling plays an
important role in AF promotion has been established for
almost 20 years (39). Atrial ion-current remodeling has
always been associated with cardiomyocyte ion currents,
but here we show for the first time (to our knowledge) that
the fibroblast ion-current remodeling occurring with AF-
promoting pathologies might affect AF susceptibility.
The remodeling of ion currents in fibroblasts coupled to
cardiomyocytes was able to contribute to the AF-maintain-
ing substrate via electrotonic interactions that modified
cardiomyocyte electrical function in profibrillatory ways.
We also found that reducing IKv,fb could counter the profi-
brillatory effect of IKir,fb upregulation and lead to reentry
termination (Fig. 8), providing a proof-of-principle for the
plausibility of targeting the ion currents of cardiomyocyte-
coupled fibroblasts for antiarrhythmic purposes. Conversely,
one could target IKir,fb, as upregulation of this current was
clearly found to facilitate reentry. Traditional cardiomyo-
cyte Kþ-channel blockers are moderately effective antiar-rhythmic agents; however, their use is severely limited by
ventricular proarrhythmic risk (e.g., torsade de pointes), re-
sulting from APD and QTc prolongation (40). A selective
blocker of fibroblast Kv or Kir current with little action on
corresponding cardiomyocyte currents might convey antiar-
rhythmic activity, with the benefit of interacting with atrial
tissue predominantly in areas of fibrosis, thereby theoreti-
cally avoiding the risk of Kþ channel blocker-induced
ventricular proarrhythmia. If significant atrial fibroblast-car-
diomyocyte coupling is confirmed in vivo, it might be of in-
terest to search for molecular and/or functional differences
between cardiomyocyte and fibroblast Kþ channels as a ba-
sis for developing fibroblast-selective pharmacological
agents.
Targeting fibroblast ionic currents for antiarrhythmic
drug therapy might have applications beyond rhythm con-
trol of AF. Ventricular tachyarrhythmias in patients with
ischemic cardiomyopathies are a major source of cardio-
vascular morbidity and a leading cause of sudden cardiac
death (41). These arrhythmias often originate in postinfarc-
tion scars with complex networks of viable and hibernating
myocardium imbedded within the area of infarction, mak-
ing such highly proarrhythmic lesions difficult to treat via
catheter ablation (42). Targeting ventricular fibroblast ion
currents to produce antiarrhythmic electrophysiological
changes in and around the infarct site may provide a new
paradigm for the management of complex ventricular ar-
rhythmias (43). Evidence suggests that modulating the
fibroblast ATP-regulated Kþ current may be exploited to
alter border-zone electrophysiology in infarcted hearts
(44).Potential limitations
A significant limitation of this work is the lack of in vivo
evidence of cardiomyocyte-fibroblast electrical coupling.
Several studies have demonstrated the existence of cardio-
myocyte-fibroblast electrical coupling in experimental co-
cultured media. Nevertheless, with the exception of work
on the sinoatrial node (16), up to now, it has not been tech-
nically possible to determine whether such coupling occurs
in vivo. Despite extensive experimentation with a variety of
in vitro systems, this fundamental question remains to be
resolved to establish the in vivo relevance of cardiomyo-
cyte-fibroblast electrical interactions in the heart. Establish-
ing the significance of fibroblast electrical remodeling in the
pathogenesis of AF remains critically dependent on experi-
mental validation of electrical coupling between cardiomyo-
cytes and fibroblasts in the atrium in situ.
In this work, we only considered cardiomyocyte-fibro-
blast coupling (single-sided connections in Kohl and Camel-
liti’s (46) terminology), and did not consider that fibroblasts
may couple to more than one cardiomyocyte at a time,
creating electrical connections between previously discon-
nected cardiomyocytes (double-sided connections). WeBiophysical Journal 107(10) 2444–2455
2454 Aguilar et al.used a single specific value for Ggap, knowing that the
magnitude of this parameter can have a significant impact
on the dynamics of cardiomyocyte-fibroblast coupling
(19). We selected a Ggap that is well within experimentally
reported values, which range from 0.31 to 8 nS (13,14). In
addition, we examined limited combinations of conditions
of fibroblast coupling and numbers of fibroblasts coupled
to cardiomyocytes (Nfb). Fig. S10 shows a further examina-
tion of the parameter space, varying Nfb, Ggap, and Cm,fb.
Some of the parameter manipulations had the expected ef-
fects (e.g., decreasing Nfb or Cm,fb attenuated the effects
of ionic remodeling, reducing Cm,fb, and reducing Ggap
virtually eliminated the effect of IKv,fb downregulation).
Increasing these variables had no clear effect, perhaps
because the default values were already sufficiently large
that further increases produced little additional change.
We also did not include the HF-induced cardiomyocyte
ionic and capacitance remodeling. A limited set of simula-
tions with remodeled cardiomyocytes did not qualitatively
change the nature of our results (Fig. S9). Furthermore,
we used a 2D sheet to study the effect of fibroblast electrical
remodeling on reentry dynamics. This choice led to the
introduction of geometrical constraints that can potentially
bias arrhythmia sustainability in situations of increased
meandering, leading to rotor extinction on substrate bound-
aries, with substrate size being an important determinant of
reentry maintenance.
Finally, we used a fibroblast ionic model that was devel-
oped based on observations in ventricular fibroblasts
(20). Burstein et al. (47) showed that atrial and ventric-
ular fibroblasts behave and proliferate differently. How-
ever, they did not identify any ion-channel subunit
expression differences by genome-wide analysis, and
recent work suggests that atrial and ventricular IKv,fb differ
significantly only at physiologically nonrelevant voltages
positive to þ60 mV (24). In addition, there were no differ-
ences in IKv,fb for atrial versus ventricular fibroblasts from
HF dogs (24).CONCLUSIONS
HF induces fibroblast ion-current remodeling: fibroblast Kv
current is downregulated, whereas fibroblast Kir current is
upregulated. Mathematical modeling indicates antifibrilla-
tory effects of IKv,fb downregulation and profibrillatory ef-
fects of IKir,fb upregulation, and reveals the underlying
electrophysiological mechanisms. Therefore, the outcome
of fibroblast electrical remodeling in atria with a disease-
induced AF substrate will critically depend on the balance
between pro- and antifibrillatory changes. If efficient electri-
cal coupling between atrial fibroblasts and cardiomyocytes
can be confirmed in vivo, pharmacological modulation of
fibroblast Kþ currents might be useful as a potential AF-se-
lective target for antiarrhythmic drug therapy. These find-
ings provide new insights (to our knowledge) into theBiophysical Journal 107(10) 2444–2455potential role of fibroblasts in the pathogenesis and treat-
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